http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 29 Sep 2025 07:32:31 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html <p>Investing.com -- AstraZeneca PLC (LON:AZN) said Monday it plans to move its U.S. trading venue to the New York Stock Exchange (NYSE), shifting from its current Nasdaq listing of American depositary receipts. The company said the change will give it access to a wider investor base.</p> <p>The Anglo-Swedish drugmaker said it will remain headquartered and tax resident in the U.K., with listings in London and Stockholm intact.</p> <p>Shares in AstraZeneca rose 1.5% in early London trading. </p> <p>"We set out our proposed harmonised listing structure which will support our long-term strategy for sustainable growth, while remaining headquartered in the UK and listed in London, http://www.streetinsider.com/Investing/AstraZeneca+to+list+directly+on+NYSE+while+keeping+U.K.+listing%3B+shares+up/25388073.html Mon, 29 Sep 2025 07:32:31 -0400 AHT ASHTY AZN AZNA AZNCF AZNH AZNN GLCNF GLEN GLENN GLNCY GLNJ PHLL ULVR http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html <p>Investing.com -- AstraZeneca (LON:AZN) said on Wednesday its asthma treatment Fasenra did not meet the primary endpoint in a late-stage trial for patients with chronic obstructive pulmonary disease (COPD).</p> <p>The company noted that the safety and tolerability seen in the RESOLUTE trial were in line with the medicine’s existing profile. It added that a full analysis of the trial results will be conducted and later shared with the scientific community.</p> <p>Fasenra is already approved as an add-on therapy for severe eosinophilic asthma in more than 80 markets, including the U.S., EU, Japan and China.</p> <p>It is also cleared in the U.S. and Japan http://www.streetinsider.com/Investing/AstraZeneca+says+Fasenra+misses+main+goal+in+COPD+trial/25342955.html Wed, 17 Sep 2025 06:49:13 -0400 AZN AZNA AZNCF AZNN GLAXF GSK GSKN MRK RHHBY RHHVF RO ROCHE ROG ROGN SANF SASY SNY SNYN